132 related articles for article (PubMed ID: 22585739)
1. Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation.
Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
Eur J Immunol; 2012 Aug; 42(8):2142-51. PubMed ID: 22585739
[TBL] [Abstract][Full Text] [Related]
2. NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.
Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
J Leukoc Biol; 2014 Mar; 95(3):487-95. PubMed ID: 24168855
[TBL] [Abstract][Full Text] [Related]
3. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells.
Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP
Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026
[TBL] [Abstract][Full Text] [Related]
4. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
[TBL] [Abstract][Full Text] [Related]
5. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
[TBL] [Abstract][Full Text] [Related]
6. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
7. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
8. IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
Song H; Park H; Kim J; Park G; Kim YS; Kim SM; Kim D; Seo SK; Lee HK; Cho D; Hur D
Immunol Lett; 2011 May; 136(2):187-93. PubMed ID: 21277902
[TBL] [Abstract][Full Text] [Related]
9. Immune protection function of multipotent mesenchymal stromal cells: role of transforming growth factor-β1.
Zhao ZG; Cao Z; Xu W; Sun L; You Y; Li F; Li QB; Zou P
Cancer Invest; 2012 Nov; 30(9):646-56. PubMed ID: 23020627
[TBL] [Abstract][Full Text] [Related]
10. An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins.
Hemsath L; Dvorsky R; Fiegen D; Carlier MF; Ahmadian MR
Mol Cell; 2005 Oct; 20(2):313-24. PubMed ID: 16246732
[TBL] [Abstract][Full Text] [Related]
11. Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
von Lilienfeld-Toal M; Frank S; Leyendecker C; Feyler S; Jarmin S; Morgan R; Glasmacher A; Märten A; Schmidt-Wolf IG; Brossart P; Cook G
Cancer Immunol Immunother; 2010 Jun; 59(6):829-39. PubMed ID: 20024547
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.
Sugita J; Tanaka J; Yasumoto A; Shiratori S; Wakasa K; Kikuchi M; Shigematsu A; Kondo T; Asaka M; Imamura M
Ann Hematol; 2010 Feb; 89(2):115-20. PubMed ID: 19578849
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2.
Tomasevic N; Jia Z; Russell A; Fujii T; Hartman JJ; Clancy S; Wang M; Beraud C; Wood KW; Sakowicz R
Biochemistry; 2007 Mar; 46(11):3494-502. PubMed ID: 17302440
[TBL] [Abstract][Full Text] [Related]
14. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice.
Huang M; Sun R; Wei H; Tian Z
Hepatology; 2013 Jan; 57(1):277-88. PubMed ID: 22806577
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
19. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
20. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]